The Arizona State Board of Optometry (“Board”) website linked to www.optometry.az.gov (“website”) is the official website of the agency for providing license lookup and license verification information. The website receives and hosts the information directly from the Board database in an electronic manner protected from alteration by unauthorized individuals.
Consistent with JCAHO, NCQA, and other standards for primary source verification, the site is considered a primary source for Board data and is the same information the agency provides through other means such as its IVR system at 602-542-3095, fax, mail or e-mail and is true and complete to the best of our knowledge. The information is updated daily at p.m. and the date of the most recent update is provided at the bottom of each directory page.
ATTENTION CURRENT LICENSEES:
LICENSE RENEWALS: The Board processes all license renewals within 24-48 hours from the date of receipt. If it has been longer than one week since you renewed and you have not received your renewed license in the mail, please contact the Board.
June 19, 2013- Check out upcoming statutory changes in SB1433. Go to http://www.azleg.gov/ and type 1433 in the upper right-hand corner in the "Bill Number Search" field. See the Chaptered Version under "Bill Versions". Changes will be effective
90 days sine die (~Sept. 12, 2013).
In the 1st regular session of the fiftieth legislature (2011)- An amendment to A.R.S. §41-1080 constitutes that the Citizenship Verification Form (CVF) with documentation is now required for initial licensure only. Once you have submitted the CVF with proper documentation to the Board, it will not be necessary to resubmit at renewal unless you are not a permanent resident of the United States and your citizenship status/documents expire.
Latisse (formerly Lumigan) is a drug that received FDA approval in 2008 as a treatment for hypotrichosis of the eyelashes, the condition of having inadequate or not enough eyelashes, and is marketed for both therapeutic and cosmetic purposes.
Arizona therapeutically certified optometrists may prescribe a pharmaceutical agent for the treatment of an abnormal condition of the visual system but not for cosmetic purposes. Therefore, while “hypotrichosis” is a relative term, a licensed optometrist who holds a therapeutic pharmaceutical agents (PA) certificate may prescribe Latisse for a diagnosed condition of hypotrichosis supported by proper documentation in the patient’s record. Doctors holding only a DPA or TPA certificate may NOT prescribe Latisse.
Do you know about the voluntary Department of Transportation reporting law?
Pursuant to A.R.S. §28-3005, optometrists may voluntarily report a patient (to the Department of Motor Vehicles) who has a medical condition that, in the opinion of the optometrist, could significantly impair the person's ability to safely operate a motor vehicle.
The full text of this statute can be found at the following link:
The law also states that the optometrist providing the information to the director in good faith is immune from personal liability with respect to the information being provided.
Prescription Disclaimers - Please be aware that pursuant to 16 C.F.R. §456.2(d), it is an unfair act or practice for an ophthalmologist or optometrist to place on the prescription, or require the patient to sign, or deliver to the patient a form or notice waiving or disclaiming the liability or responsibility of the ophthalmologist or optometrist for the accuracy of the eye examination or the accuracy of the ophthalmic goods and services dispensed by another seller.
In addition, under the Optometry Board’s statutes at A.R.S. §32-1743(12), the Board may discipline an optometrist for any violation of any statutes, laws or rules regulating the practice of optometry in this state or any other jurisdiction of the United States.